Skip to main content
Clinical Trials/JPRN-UMIN000032341
JPRN-UMIN000032341
Completed
未知

Prospective analysis of cardiovascular events based on titin concentration in patients with chronic heart failure - Analysis of titin in patients with chronic heart failure

Kobe University Graduate School of Medicine Department of Internal Medicine Division of Cardiovascular Medicine0 sites70 target enrollmentMay 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
chronic heart failure
Sponsor
Kobe University Graduate School of Medicine Department of Internal Medicine Division of Cardiovascular Medicine
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2018
End Date
February 27, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kobe University Graduate School of Medicine Department of Internal Medicine Division of Cardiovascular Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients with muscular diseases (e.g. muscular dystrophy (2\) Situation of muscular destruction (e.g. strenuous training, muscle infection and so on) (3\) Patients whose life expectancy is less than 24 months (4\) Other cases who are judged to be inappropriate to be included in this study by the chief investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A retrospective study of cardiac event occurrence in thoracic carbon-ion radiotherapyung cancer, liver cancer, esophageal cancer etc.
JPRN-UMIN000046354ational Institute for Quantum and Radiological Science and Technology200
Recruiting
Not Applicable
The investigation of optimal cardiovascular treatment with directional coronary atherectomyCoronary atherosclerosis Angina pectoris, Acute coronary syndrome
JPRN-UMIN000041784Hyogo Brain and Heart Center200
Active, not recruiting
Not Applicable
Estudio de eventos cardiovasculares para evaluar el potencial de aleglitazar en la reducción del riesgo cardiovascular en pacientes con un episodio reciente de síndrome coronario agudo (SCA) y diabetes mellitus tipo 2 (DM2).Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D).Pacientes con diabetes tipo 2 con un episodio reciente de síndrome coronario agudo (SCA).Type 2 diabetes patients with a recent acute coronary syndrome (ACS) event.MedDRA version: 12.0Level: LLTClassification code 10007649Term: Cardiovascular disorder
EUCTR2009-012269-71-ESF. Hoffmann-La Roche Ltd.6,000
Completed
Not Applicable
A prospective surveillance of cardiovascular events in antiplatelet-treated arteriosclerosis obliterans patients in Japan.Arteriosclerosis obliterans Peripheral arterial disease
JPRN-UMIN000003385Mitsubishi Tanabe Pharma Corporation11,375
Recruiting
Not Applicable
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cellscardiovascular adverse events after cancer treatment1008220610027655
NL-OMON44465niversitair Medisch Centrum Groningen48